SCHEMBL29566397

SCHEMBL29566397

Cc1ccccc1Oc1cc(-c2ccccc2C)nc(NS(=O)(=O)c2cccc([N+](=O)[O-])c2)n1

nearest known ligand 0.50

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.49
▸ PGR P06401 1/20 0.46
▸ NFKBIA P25963 1/20 0.46
▸ RELA Q04206 1/20 0.46
▸ ALDH1A1 P00352 2/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ MAPT P10636 1/20 0.45
▸ EDNRA P25101 2/20 0.45
▸ DDX3X O00571 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ EDNRB P24530 1/20 0.43
▸ KMT2A Q03164 3/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ AR P10275 1/20 0.43
▸ TYMS P04818 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309260 1.00 LMNA (0.49) LMNAPGRNFKBIARELAALDH1A1
SCHEMBL24309602 0.91 PGR (0.56) LMNAPGRNFKBIARELAALDH1A1
SCHEMBL29568117 0.91 PGR (0.56) LMNAPGRNFKBIARELAALDH1A1
SCHEMBL29566551 0.90 LMNA (0.44) LMNAPGRNFKBIARELAALDH1A1
SCHEMBL24310352 0.90 LMNA (0.44) LMNAPGRNFKBIARELAALDH1A1
SCHEMBL24309251 0.87 LMNA (0.52) LMNAPGRNFKBIARELAALDH1A1
SCHEMBL29566909 0.87 LMNA (0.52) LMNAPGRNFKBIARELAALDH1A1
SCHEMBL24310315 0.87 LMNA (0.46) LMNAPGRNFKBIARELAALDH1A1
SCHEMBL24309286 0.86 PGR (0.48) LMNAPGRNFKBIARELAALDH1A1
SCHEMBL29566653 0.86 PGR (0.48) LMNAPGRNFKBIARELAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback